American Express (AXP)

NYSEFinancialsFinancial - Credit ServicesSnapshot 2026-10-15

$313.59-0.09%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge American Express’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.3%

+10% or more+5%0%−5%−10% or less

20.17 → 20.11 EPS · FY ending Dec 31, 2027 · 22 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 21 to 22; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain strong customer engagement and brand with Apple Pay and NFL deal	New deals and Apple Pay rewards support growth.	Intact	Loss of key partnerships or decline in customer engagement	Qualitative: Partnerships intact, engagement expanding New Centurion lounges announced; Fitch upgraded AXP to A+ citing premium reach. AML fine noted but does not break partnership moat. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Increase quarterly dividend to $0.95	The company raised its quarterly dividend to $0.95 per share.	Intact	Dividend falls below $0.90 per share in FY26	Dividend per share: $0.95 per share FY2026-Q2; GAAP. Published target: Quarterly dividend $0.95 per share. Target period is not explicitly aligned with this observation. Source published Jul 24, 20260.95 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1dbff979-04ab-4730-8ede-cb0be2ad9d09. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. The quarterly dividend increased from $0.82 in 2025-Q3 to $0.95 in 2026-Q1 as announced. Management has executed on this capital allocation priority, delivering the planned dividend increase. Delivery assessment Oct 15, 2026
EPS between $17.30 and $17.90 in 2026	EPS is guided between $17.30 and $17.90 for 2026.	Under Pressure	EPS falls below $16.5 in FY26	Diluted EPS: $4.53 per share FY2026-Q2; GAAP. Published target: EPS $17.30 to $17.90. Target period is not explicitly aligned with this observation. Source published Jul 24, 20264.53 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1dbff979-04ab-4730-8ede-cb0be2ad9d09. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Diluted EPS increased from $3.64 in 2025-Q1 to $4.28 in 2026-Q1, with management maintaining full-year 2026 EPS guidance of $17.30 to $17.90. The trajectory shows consistent EPS growth and management is delivering on this guidance. Delivery assessment Oct 15, 2026
Achieve 9-10% revenue growth in 2026	A primary condition in American Express's published investment case. The stated target is 9-10% YoY revenue growth.	Under Pressure	YoY revenue growth falls below 7% in FY26	Revenue growth: 8.63% FY2026-Q2; GAAP. Published target: 9-10% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Jul 24, 20268.632884 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1dbff979-04ab-4730-8ede-cb0be2ad9d09. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Revenue grew from $9.63B in 2025-Q1 to $10.52B in 2026-Q1, with 2026-Q2 revenue at $19.6B, up 10% year-over-year. Management has consistently guided for 9-10% revenue growth in 2026 and recently raised the guidance to 10%, indicating delivery and positive trajectory. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$20.11

$20.15 → $20.11 · observed estimates

FY2027 revenue$86.59B

$86.55B → $86.59B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$20.15	$86,545,013,930	28 / 24
2026-07-25	$20.11	$86,624,287,360	28 / 24
2026-07-26	$20.11	$86,624,287,360	28 / 24
2026-07-27	$20.09	$86,633,306,240	28 / 24
2026-07-28	$20.09	$86,633,306,240	28 / 24
2026-07-29	$20.10	$86,714,088,300	28 / 24
2026-07-30	$20.12	$86,609,774,033	22 / 18
2026-07-31	$20.10	$86,714,088,300	28 / 24
2026-08-01	$20.11	$86,674,567,810	22 / 18
2026-08-02	$20.12	$86,734,254,970	27 / 24
2026-08-03	$20.12	$86,734,254,970	27 / 24
2026-08-04	$20.12	$86,734,254,970	27 / 24
2026-08-05	$20.12	$86,733,504,910	27 / 24
2026-08-06	$20.12	$86,733,504,910	27 / 24
2026-08-07	$20.12	$86,674,567,810	21 / 18
2026-08-08	$20.11	$86,751,029,230	28 / 24
2026-08-09	$20.11	$86,751,029,230	28 / 24
2026-08-10	$20.11	$86,751,029,230	28 / 24
2026-08-11	$20.11	$86,772,279,230	28 / 24
2026-08-12	$20.11	$86,772,279,230	28 / 24
2026-08-13	$20.11	$86,772,279,230	28 / 24
2026-08-14	$20.12	$86,674,567,810	21 / 18
2026-08-15	$20.12	$86,674,567,810	22 / 18
2026-08-16	$20.12	$86,674,567,810	22 / 18
2026-08-17	$20.12	$86,674,567,810	22 / 18
2026-08-18	$20.12	$86,674,567,810	22 / 18
2026-08-19	$20.12	$86,674,567,810	22 / 18
2026-08-20	$20.12	$86,716,067,762	22 / 18
2026-08-21	$20.12	$86,716,067,762	22 / 18
2026-08-22	$20.12	$86,716,067,762	22 / 18
2026-08-23	$20.12	$86,716,067,762	22 / 18
2026-08-24	$20.12	$86,716,067,762	22 / 18
2026-08-25	$20.12	$86,716,067,762	22 / 18
2026-08-26	$20.12	$86,716,067,762	22 / 18
2026-08-27	$20.12	$86,716,067,762	22 / 18
2026-08-28	$20.12	$86,716,067,762	22 / 18
2026-08-29	$20.12	$86,716,067,762	22 / 18
2026-08-30	$20.12	$86,716,067,762	22 / 18
2026-08-31	$20.12	$86,716,067,762	22 / 18
2026-09-01	$20.12	$86,716,067,762	22 / 18
2026-09-02	$20.12	$86,716,067,762	22 / 18
2026-09-03	$20.12	$86,716,067,762	22 / 18
2026-09-04	$20.12	$86,716,067,762	22 / 18
2026-09-05	$20.12	$86,716,067,762	22 / 18
2026-09-06	$20.12	$86,716,067,762	22 / 18
2026-09-07	$20.12	$86,716,067,762	22 / 18
2026-09-08	$20.12	$86,716,067,762	22 / 18
2026-09-09	$20.13	$86,694,244,057	21 / 18
2026-09-10	$20.17	$86,665,158,671	21 / 18
2026-09-11	$20.17	$86,665,158,671	21 / 18
2026-09-12	$20.17	$86,665,158,671	21 / 18
2026-09-13	$20.17	$86,665,158,671	21 / 18
2026-09-14	$20.17	$86,665,158,671	21 / 18
2026-09-15	$20.17	$86,665,158,671	21 / 18
2026-09-16	$20.17	$86,665,158,671	21 / 18
2026-09-17	$20.17	$86,665,158,671	21 / 18
2026-09-18	$20.17	$86,665,158,671	21 / 18
2026-09-19	$20.17	$86,665,158,671	21 / 18
2026-09-20	$20.17	$86,665,158,671	22 / 18
2026-09-21	$20.17	$86,665,158,671	22 / 18
2026-09-22	$20.16	$86,677,737,655	22 / 18
2026-09-23	$20.16	$86,653,737,655	22 / 18
2026-09-24	$20.16	$86,653,737,655	22 / 18
2026-09-25	$20.16	$86,645,023,369	21 / 18
2026-09-26	$20.16	$86,645,023,369	21 / 18
2026-09-27	$20.16	$86,645,023,369	21 / 18
2026-09-28	$20.16	$86,645,023,369	21 / 18
2026-09-29	$20.15	$86,648,213,845	21 / 18
2026-09-30	$20.15	$86,648,213,845	21 / 18
2026-10-01	$20.14	$86,625,926,568	21 / 18
2026-10-02	$20.14	$86,619,890,257	21 / 18
2026-10-03	$20.14	$86,619,890,257	21 / 18
2026-10-04	$20.14	$86,619,890,257	21 / 18
2026-10-05	$20.14	$86,619,890,257	21 / 18
2026-10-06	$20.12	$86,568,495,447	21 / 18
2026-10-07	$20.11	$86,560,964,771	21 / 18
2026-10-08	$20.12	$86,525,099,295	21 / 18
2026-10-09	$20.12	$86,525,099,295	21 / 18
2026-10-10	$20.12	$86,525,099,295	21 / 18
2026-10-11	$20.13	$86,607,749,165	22 / 18
2026-10-12	$20.13	$86,607,749,165	22 / 18
2026-10-13	$20.12	$86,586,824,777	22 / 18
2026-10-14	$20.12	$86,586,824,777	22 / 18
2026-10-15	$20.11	$86,586,824,777	22 / 18

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	13	15	1
2026-06-01	14	15	1
2026-07-01	15	15	2
2026-08-01	15	15	1
2026-09-01	15	15	1
2026-10-01	16	14	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 16 Buy / Strong Buy · 14 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades9 maintains

Recent actions · Sep 16–Oct 15 · 9 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Morgan StanleyOct 12 · prior Jul 27

$382.00 → $380.00-0.5%

RBC CapitalOct 9

$400.00New observation · no comparable prior

BMO CapitalOct 8

$380.00New observation · no comparable prior

UBSOct 5 · prior Aug 3

$384.00 → $345.00-10.2%

BarclaysOct 5 · prior Jul 7

$364.00 → $342.00-6.0%

Evercore ISIOct 1 · prior Jul 27

$370.00 → $320.00-13.5%

$0$220.00$440.00

0 raises · 4 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Increase quarterly dividend to $0.95Dividend per share: $0.95 per share
EPS between $17.30 and $17.90 in 2026Published status: Under Pressure
Achieve 9-10% revenue growth in 2026Published status: Under Pressure

Next proof point

Oct 23, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-23.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

American Express outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on steady revenue and earnings growth. The current thesis state indicates a medium confidence level, with management executing on key priorities but facing sector headwinds.

What's priced into American Express

The market appears to have priced in a stretched valuation compared to peers, with expectations for continued growth. There is a low fragility tier, suggesting that the stock is not overly sensitive to immediate shocks.

What the fundamentals likely do

Fundamentals are likely to remain stable, with management on track to achieve revenue growth and EPS targets. However, there is a moderate risk due to recent litigation and a history of misses in earnings guidance.

What American Express hinges on

The thesis hinges on management's ability to maintain guidance and the performance of sector bellwethers like Visa and Mastercard. Additionally, any changes in Federal Reserve interest rates could significantly impact AXP's performance.